CliniSciences ApS: Financial statements 2023
CVR: 42293091
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CliniSciences ApS (CVR 42293091) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 586,094 and a net result of DKK -392,813 compared with DKK -276,088 the year before. That is an increase of 6.6% compared with the year before. Equity in the 2023 report amounted to DKK -438,894.
- Gross Profit
- DKK 586,094
- Profit/Loss
- DKK -392,813
- Equity
- DKK -438,894
- Total Assets
- DKK 2,179,680
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CliniSciences ApS has won the tender "Udbud af rammeaftale vedr. avancerede kemikalier" issued by Aalborg Universitet.
CliniSciences ApS has published its annual report for 2022. Gross profit came to DKK 549,726, and the net result was DKK -276,088.
About CliniSciences ApS
CliniSciences ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2021. The company is registered under the industry Administrations- og kontorserviceaktiviteter. The management consists of Rasiah Alexandre Rushentan. The company is owned by Cliniholding SARL. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 846,022 and a net result of DKK -54,396 compared with DKK -190,553 the year before. Equity in the 2025 report amounted to DKK -683,843.